Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katrien Van Roosbroeck

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Cancer Metastasis Reviews|December 29, 2017
miR-155 in cancer drug resistance and as target for miRNA-based therapeuticsRecep Bayraktar, Katrien Van Roosbroeck
Blood|April 23, 2016
When kissing (disease) countsKatrien Van Roosbroeck, George A Calin
Advances in Cancer Research|September 9, 2017
Cancer Hallmarks and MicroRNAs: The Therapeutic ConnectionKatrien Van Roosbroeck, George A Calin
Seminars in Oncology|April 5, 2016
MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies?Katrien Van Roosbroeck, George A Calin
Cancer Metastasis Reviews|December 30, 2017
PrefaceGeorge A Calin, Katrien Van Roosbroeck
Methods in Molecular Biology (Clifton, N.J.)|October 24, 2018
Measurement of miRNAs in Chronic Lymphocytic Leukemia Patient Samples by Quantitative Reverse Transcription PCRKatrien Van Roosbroeck, Recep Bayraktar, George A Calin
Expert Review of Molecular Diagnostics|March 13, 2013
miRNAs and long noncoding RNAs as biomarkers in human diseasesKatrien Van Roosbroeck, Jeroen Pollet, George A Calin
Leukemia & Lymphoma|August 6, 2014
Long non-coding RNAs in primary myelofibrosis: the dark matter in hematopoietic progenitor cells?Katrien Van Roosbroeck, Srdan Verstovsek, George A Calin
Molecular Oncology|October 13, 2017
Cell-to-cell communication: microRNAs as hormonesRecep Bayraktar, Katrien Van Roosbroeck, George A Calin
Leukemia Research|January 11, 2012
PDS5A, a novel translocation partner of MLL in acute myeloid leukemiaNatalie Put, Katrien Van Roosbroeck, Isabelle Vande Broek, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Cancer Metastasis Reviews|December 29, 2017
miR-155 in cancer drug resistance and as target for miRNA-based therapeuticsRecep Bayraktar, Katrien Van Roosbroeck
Blood|April 23, 2016
When kissing (disease) countsKatrien Van Roosbroeck, George A Calin
Advances in Cancer Research|September 9, 2017
Cancer Hallmarks and MicroRNAs: The Therapeutic ConnectionKatrien Van Roosbroeck, George A Calin
Seminars in Oncology|April 5, 2016
MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies?Katrien Van Roosbroeck, George A Calin
Cancer Metastasis Reviews|December 30, 2017
PrefaceGeorge A Calin, Katrien Van Roosbroeck
Methods in Molecular Biology (Clifton, N.J.)|October 24, 2018
Measurement of miRNAs in Chronic Lymphocytic Leukemia Patient Samples by Quantitative Reverse Transcription PCRKatrien Van Roosbroeck, Recep Bayraktar, George A Calin
Expert Review of Molecular Diagnostics|March 13, 2013
miRNAs and long noncoding RNAs as biomarkers in human diseasesKatrien Van Roosbroeck, Jeroen Pollet, George A Calin
Leukemia & Lymphoma|August 6, 2014
Long non-coding RNAs in primary myelofibrosis: the dark matter in hematopoietic progenitor cells?Katrien Van Roosbroeck, Srdan Verstovsek, George A Calin
Molecular Oncology|October 13, 2017
Cell-to-cell communication: microRNAs as hormonesRecep Bayraktar, Katrien Van Roosbroeck, George A Calin
Leukemia Research|January 11, 2012
PDS5A, a novel translocation partner of MLL in acute myeloid leukemiaNatalie Put, Katrien Van Roosbroeck, Isabelle Vande Broek, et al.
Pageof 3